Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
peptides
Biotech
Genentech signs off on $1B biobucks to expand PeptiDream collab
Big Pharmas have been queueing up to collaborate with PeptiDream, and, now, Genentech is back with $40 million upfront for a fresh licensing agreement.
James Waldron
Sep 20, 2023 7:14am
Theratechnologies halts lead cancer trial over efficacy concerns
Dec 2, 2022 5:35am
Windtree sheds weight, enters near $80M biobucks deal
Aug 23, 2022 11:54am
Crinetics creates Radionetics with $30M for 10 cancer candidates
Oct 18, 2021 4:14pm
Gubra, Bayer ink $253M biobucks deal for heart, kidney collab
Sep 20, 2021 10:50am
PeptiDream signs licensing deal with Alnylam worth up to $2.2B
Jul 30, 2021 10:05am